Lidocaine Baxter (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve and cardiac cell membranes, preventing the rapid influx of sodium ions needed for depolarization. This stops the transmission of pain signals and suppresses abnormal cardiac pacemaker activity, resulting in anesthesia and anti‑arrhythmic effects.

The dose of Lidocaine Baxter is determined by the prescribing clinician based on the specific indication, patient characteristics, and route of administration. Healthcare professionals calculate the appropriate amount to achieve the desired anesthetic or anti‑arrhythmic effect while minimizing toxicity.

Safety data for Lidocaine Baxter in pregnancy are limited, and the product is classified as pregnancy category unknown. It should only be used when the potential benefit outweighs any possible risk to the fetus. Breastfeeding mothers should consult their healthcare provider, as lidocaine can be excreted in breast milk.

To order Lidocaine Baxter, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lidocaine is a widely used amide‑type local anesthetic offering rapid onset and moderate duration of action. Compared with agents such as bupivacaine, lidocaine has a shorter half‑life and lower cardiotoxic potential, making it suitable for shorter procedures and acute cardiac use, whereas bupivacaine provides longer analgesia but carries higher risk of cardiac toxicity.

Lidocaine Baxter should be stored at room temperature, below 25 °C, in its original packaging. Protect the solution from moisture, direct sunlight, and extreme temperature fluctuations. Ensure the vial or ampoule remains sealed until use to maintain sterility.

Lidocaine Baxter is administered intravenously by a qualified healthcare professional. The solution is injected directly into a vein or used to infiltrate tissues for local or regional anesthesia, following aseptic technique and appropriate dosing calculations based on the clinical indication.

Serious risks include severe hypotension, cardiac arrest, profound bradycardia, seizures, allergic reactions such as anaphylaxis, and methemoglobinemia. These events are rare but require immediate medical intervention and close monitoring, especially during high‑dose or rapid‑infusion protocols.

Lidocaine Baxter should be avoided in patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block without a pacemaker, and individuals receiving concurrent class I antiarrhythmic drugs unless closely monitored. Caution is also advised in patients with significant hepatic impairment.